- Aehr Test Systems (NASDAQ: AEHR) is anticipated to report strong earnings of $0.11 per share and revenue of approximately $27 million for the quarter ended August 2026, reflecting significant year-over-year growth.
- The company’s fiscal 2027 outlook projects substantial revenue growth of 160% to 200%, driven by robust demand in AI and data-center chip testing, supported by a record backlog of $100.60 million.
- Despite a high price-to-sales ratio of 65.32, Aehr Test Systems’ strong AI-related demand and growth prospects strengthen its investment case, making backlog quality and shipment schedules crucial watch points.
Aehr Test Systems (NASDAQ: AEHR) is expected to report earnings on October 5, 2026, after the market closes. Aehr Test Systems makes equipment that tests semiconductors before they reach customers. Analysts expect earnings of $0.11 per share and revenue of about $27 million for the quarter ended August 2026.
The $0.11 earnings estimate represents a 1,000% increase from a year earlier. Earnings per share show how much profit a company makes for each share of stock. Aehr Test Systems’ share-price reaction may depend on whether it beats or misses the estimates, as highlighted by Zacks Investment Research.
Beyond the quarter, management expects fiscal 2027 revenue of $130 million to $150 million, or roughly 160% to 200% year-over-year growth. Aehr Test Systems also forecasts a non-GAAP net income margin of 18% to 22%. That margin measures expected profit as a share of revenue after excluding certain accounting items.
Aehr Test Systems’ record effective backlog of about $100.60 million supports its outlook. Backlog is the value of orders not yet filled, though the timing of shipments matters. Demand for AI and data-center chip testing is a key driver. As highlighted by Seeking Alpha, backlog quality, shipment schedules and follow-on orders are important to watch in the report.
Aehr Test Systems competes with other semiconductor equipment makers, including Camtek (NASDAQ: CAMT). As highlighted by Zacks, Aehr Test Systems’ AI-related demand and growth outlook strengthen its investment case, despite its higher valuation. Camtek gets roughly 75% of its second-quarter 2026 revenue from advanced packaging. Aehr Test Systems’ price-to-sales ratio of 65.32 shows investors pay $65.32 for each $1.00 of annual sales.
